Nuclear factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1

Retrovirology

Volumn 4, Issue , 2007, Pages

  Agbottah, Emmanuel T ^a   Traviss, Christine ^a   McArdle, James ^a   Karki, Sambhav ^a   St Laurent III, Georges C ^a   Kumar, Ajit ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; HISTONE H3; INTERLEUKIN ENHANCER BINDING FACTOR 3; LYSINE; TRANSACTIVATOR PROTEIN; HISTONE; RNA BINDING PROTEIN; VIRUS RNA;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHROMATIN; CONTROLLED STUDY; EPIGENETICS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE INTERACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NORTHERN BLOTTING; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN METHYLATION; PROTEIN TARGETING; PROTEIN VARIANT; RNA TRANSCRIPTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS ACTIVATION; VIRUS CELL INTERACTION; WESTERN BLOTTING; BINDING SITE; CELL FRACTIONATION; CELL LINE; DRUG ANTAGONISM; HELA CELL; IMMUNOLOGY; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; METABOLISM; METHYLATION; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

BINDING SITES; CELL FRACTIONATION; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE PRODUCTS, TAT; HELA CELLS; HISTONES; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; JURKAT CELLS; METHYLATION; NUCLEAR FACTOR 90 PROTEINS; PROTEIN BINDING; RNA, DOUBLE-STRANDED; RNA, VIRAL; RNA-BINDING PROTEINS; TRANS-ACTIVATION (GENETICS);

EID: 34447341184     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-4-41     Document Type: Article

References (57)

1. Siliciano RF HIV replication and evolution in patients with highly active antiretrovirus therapy Retrovirology 2006 3 S11 10.1186/ 1742-4690-3-S1-S11
2. Pido-Lopez J Burton C Hardy G Pires A Sullivan A Gazzard B Aspinall R Gotch F Imami N Thymic Output during Initial Highly Active Antiretroviral Therapy (HAART) and during HAART Supplementation with Interleukin 2 and/or with HIV Type 1 Immunogen (Remune) AIDS Res Hum Retroviruses 2003 19 103-109 10.1089/088922203762688603 12639245
3. Chun RF Jeang KT Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human T-cell lymphotropic virus 1 and HIV-1 J Biol Chem 1996 271 27888-94 10.1074/jbc.271.44.27888 8910388
4. Raha T Cheng SW Green MR HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs PLoS Biol 2005 3 221-234 10.1371/journal.pbio.0030044
5. Wang Z Rana TM RNA-protein interactions in the Tat-trans-activation response element complex determined by site-specific photo-cross-linking Biochemistry 1998 37 4235-4243 10.1021/bi972889a 9521746
6. Berkhout B Jeang KT Detailed mutational analysis of TAR RNA: Critical spacing between the bulge and loop recognition domains Nucleic Acids Res 1991 19 6169-6176 329115 1956776 10.1093/nar/19.22.6169
7. Lund LH Wahren B Garcia-Blanco MA A functional genetic approach suggests a novel interaction between the human immunodeficiency virus type 1 (HIV-1) Tat protein and HIV-1 TAR RNA in vivo J Gen Virol 2003 84 603-606 10.1099/vir.0.18645-0 12604811
8. Berkhout B Gatignol A Rabson AB Jeang KT TAR-independent activation of the HIV-1 LTR: Evidence that tat requires specific regions of the promoter Cell 1990 62 757-767 10.1016/0092-8674(90)90120-4 2201451
9. Laspia MF Rice AP Mathews MB HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation Cell 1989 59 283-292 10.1016/ 0092-8674(89)90290-0 2553266
10. Selby MJ Bain ES Luciw PA Peterlin BM Structure, sequence, and position of the stem-loop in TAR determine transcriptional elongation by Tat through HIV-1 long terminal repeat Genes Dev 1989 3 547-558 10.1101/ gad.3.4.547 2470647
11. Brady J Kashanchi F Tat gets the "green" light on transcription initiation Retrovirology 2005 2 69 1308864 16280076 10.1186/1742-4690-2-69
12. Zhou M Deng L Lacoste V Park HU Pumfery A Kashanchi F Brady JN Kumar A Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription J Virol 2004 78 13522-13533 533906 15564463 10.1128/ JVI.78.24.13522-13533.2004
13. Benkirane M Chun RF Xiao H Ogryzko VV Howard BH Nakatani Y Jeang KT Activation of integrated provirus requires histone acetyltransferase: p300 and P/CAF are coactivators for HIV-1 Tat J Biol Chem 1998 273 24898-24905 10.1074/jbc.273.38.24898 9733796
14. Zhou Q Sharp PA Tat-SF1: Cofactor for Stimulation of Transcriptional Elongation by HIV-1 Tat Science 1996 274 605-610 10.1126/ science.274.5287.605 8849451
15. Smith C Lee SW Wong E Gallardo H Page K Gaspar O Lebkowski J Gilboa E Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys Antiviral Res 1996 32 99-115 10.1016/ 0166-3542(95)00987-6 8891169
16. Lisziewicz J Sun D Smythe J Lusso P Lori F Louie A Markham P Rossi J Reitz M Gallo RC Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS Proc Natl Acad Sci USA 1993 90 8000-8004 47275 8367455 10.1073/pnas.90.17.8000
17. Mischiati C Finotti A Sereni A Boschetti S Baraldi PG Romagnoli R Feriotto G Jeang KT Bianchi N Borgatti M Gambari R Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA Biochem Pharmacol 2004 67 401-10 10.1016/j.bcp.2003.09.009 15037192
18. Mischiati C Jeang KT Feriotto G Breda L Borgatti M Bianchi N Gambari R Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA Antisense Nucleic Acid Drug Dev 2001 11 209-17 10.1089/108729001317022214 11572598
19. Hwang S Tamilarasu N Kibler K Cao H Ali A Ping YH Jeang KT Rana TM Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1replication J Biol Chem 2003 278 39092-103 10.1074/jbc.M301749200 12857725
20. Lohr M Kibler KV Zachary I Jeang KT Selwood DL Small HIV-1-Tat peptides inhibit HIV replication in cultured T-cells Biochem Biophys Res Commun 2003 300 609-13 10.1016/S0006-291X(02)02903-0 12504126
21. Bohjanen PR Colvin RA Puttaraju M Been MD Garcia-Blanco MA A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription Nucleic Acids Res 1996 24 3733-3738 146173 8871552 10.1093/ nar/24.19.3733
22. Wyszko E Barciszewska MZ Bald R Erdmann VA Barciszewski J The specific hydrolysis of HIV-1 TAR RNA element with the anti-TAR hammerhead ribozyme: Structural and functional implications Int J Biol Macromol 2001 28 373-380 10.1016/S0141-8130(01)00138-6 11325424
23. Ventura M Wang P Franck N Saragosti S Ribozyme targeting of HIV-1 LTR Biochem Biophys Res Commun 1994 203 889-898 10.1006/bbrc.1994.2266 8093072
24. Jeang KT Berkhout B Kinetics of HIV-1 long terminal repeat trans-activation: Use of intragenic ribozyme to assess rate-limiting steps J Biol Chem 1992 267 17891-17899 1517225
25. Poznansky MC Foxall R Mhashilkar A Coker R Jones S Ramstedt U Marasco W Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat. Hum Gene Ther 1998 9 4 487-496 9525310
26. Mhashilkar AM Biswas DK LaVecchio J Pardee AB Marasco WA Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists J Virol 1997 71 6486-6494 191923 9261367
27. Kaushik N Basu A Palumbo P Myers RL Pandey VN Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production J Virol 2002 76 3881-3891 136084 11907228 10.1128/JVI.76.8.3881-3891.2002
28. Turner JJ Ivanova GD Verbeure B Williams D Arzumanov AA Abes S Lebleu B Gait MJ Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells Nucleic Acids Res 2005 33 6837-6849 1301599 16321967 10.1093/nar/gki991
29. Tripathi S Chaubey B Ganguly S Harris D Casale RA Pandey VN Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides Nucleic Acids Res 2005 33 4345-4356 1182329 16077030 10.1093/nar/gki743
30. Krasnoselskaya-Riz I Spruill A Chen YW Schuster D Teslovich T Baker C Kumar A Stephan DA Nuclear factor 90 mediates activation of the cellular antiviral expression cascade AIDS Res Hum Retroviruses 2002 18 591-604 10.1089/088922202753747941 12036489
31. Corthesy B Kao PN Purification by DNA affinity chromatography of two polypeptides that contact the NF-AT DNA binding site in the interleukin 2 promoter J Biol Chem 1994 269 20682-20690 8051169
32. Duchange N Pidoux J Camus E Sauvaget D Alternative splicing in the human interleukin enhancer binding factor 3 (ILF3) gene Gene 2000 261 345-353 10.1016/S0378-1119(00)00495-9 11167023
33. Reichman TW Mathews MB RNA binding and intramolecular interactions modulate the regulation of gene expression by nuclear factor 110 RNA 2003 9 543-554 1370420 12702813 10.1261/rna.2181103
34. Burd CG Dreyfuss G Conserved structures and diversity of functions of RNA-binding proteins Science 1994 265 615-621 10.1126/science.8036511 8036511
35. Reichman TW Parrott AM Fierro-Monti I Caron DJ Kao PN Lee CG Li H Mathews MB Selective regulation of gene expression by nuclear factor J Mol Biol 2003 332 85-98 10.1016/S0022-2836(03)00885-4 12946349
36. Rounseville MP Kumar A Binding of a host cell nuclear protein to the stem region of human immunodeficiency virus type 1 trans-activation-responsive RNA J Virol 1992 66 1688-1694 240912 1738206
37. Marques SMP Veyrune JL Shukla RR Kumar A Restriction of human immunodeficiency virus type 1 Rev function in murine A9 cells involves the Rev C-terminal domain J Virol 2003 77 3084-3090 149738 12584334 10.1128/JVI.77.5.3084-3090.2003
38. Butera ST Roberts BD Lam L Hodge T Folks TM Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency J Virol 1994 68 2726-2730 236750 7511177
39. Zucker M PCFOLD: Version 4.0, RNA secondary Structure Cold Spring Harbor Symp Quant Biol 1987 52 123 2456874
40. Laughlin MA Zeichner S Kolson D Alwine JC Seshamma T Pomerantz RJ Gonzalez-Scarano F Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspiced viral RNA Virology 1993 196 496-505 10.1006/viro.1993.1505 8372431
41. Santos-Rosa H Schneider R Bannister AJ Active genes are tri-methylated at K4 of histone H3 Nature 2002 419 407-411 10.1038/nature01080 12353038
42. Jenuwein T The epigenetic magic of histone lysine methylation FEBS Journal 2006 273 3121-3135 10.1111/j.1742-4658.2006.05343.x 16857008
43. Urcuqui-Inchima S Castano ME Hernandez-Verdun D St Laurent G Kumar A Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function Retrovirology 2006 3 83-90 1713252 17125513 10.1186/ 1742-4690-3-83
44. Berkhout B Jeang KT Detailed mutational analysis of TAR RNA: Critical spacing between the bulge and loop recognition domains Nucleic Acids Res 1991 19 6169-76 329115 1956776 10.1093/nar/19.22.6169
45. Jeang KT Berkhout B Dropulic B Effects of integration and replication on transcription of the HIV-1 long terminal repeat J Biol Chem 1993 268 24940-9 8227056
46. Shim J Lim H R Yates J Karin M Nuclear export of NF90 is required for interleukin-2 mRNA stabilization Mol Cell 2002 10 1331-144 10.1016/ S1097-2765(02)00730-X 12504009
47. Larcher J-C Gasmi L Viranaïcken W Eddé B Ilf3 and NF90 associate with the axonal targeting element of Tau mRNA FASEB J 2004 18 1761-1763 15364895
48. Nie Y Ding L Kao PN Braun R Yang J-H ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing Mol Cell Biol 2005 25 6956-6963 1190226 16055709 10.1128/MCB.25.16.6956-6963.2005
49. Berkhout B Silverman RH Jeang KT Tat trans-activates the human immunodeficiency virus through a nascent RNA Cell 1989 59 273-282 10.1016/0092-8674(89)90289-4 2478293
50. Marciniak RA Sharp PA HIV-1 Tat protein promotes formation of more-processive elongation complexes EMBO J 1991 10 4189-4196 453171 1756726
51. Selby MJ Bain ES Luciw PA Peterlin BM Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat Genes Dev 1989 3 547-558 10.1101/ gad.3.4.547 2470647
52. Laspia MF Rice AP Mathews MB HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation Cell 1989 59 283-292 10.1016/ 0092-8674(89)90290-0 2553266
53. Ratnasabapathy R Sheldon M Johal L Hernandez N The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters Genes Dev 1990 4 2061-2074 10.1101/gad.4.12a.2061 2269426
54. Gale M Jr Foy EM Evasion of intracellular host defence by hepatitis C virus Nature 2005 436 539-545 10.1038/nature04078
55. Gatignol A Laine S Clerzius G Dual role of TRBP in HIV replication and RNA interference: Viral diversion of a cellular pathway or evasion from antiviral immunity? Retrovirology 2005 2 65 1282568 16253139 10.1186/ 1742-4690-2-65
56. Kumar A The silent defense: Micro-RNA directed defense against HIV-1 replication Retrovirology 2007 4 26 1865552 17430590 10.1186/ 1742-4690-4-26
57. Cheah MT Wachter A Sudarsan N Breaker RR Control of alternative RNA splicing and gene expression by eukaryotic riboswitches Nature 447 7143 497-500 2007 Apr 29 10.1038/nature05769 17468745